RPRD Diagnostics
Ulrich Broeckel is the founder and CEO of RPRD Diagnostics. Ulrich has also served on the board of the Wisconsin Conservatory of Music and the American Heart Association in Metro Milwaukee. Prior to their current position, they were employed at the Medical College of Wisconsin.
Dr. Ulrich Broeckel completed a residency in internal medicine at Universität Regensburg, followed by a fellowship in cardiology at Ruprecht-Karls-Universität Heidelberg. Ulrich then received their MD from Universität Ulm.
Some individuals on their team include Praful Aggarwal - Director, Informatics, Amy Turner - Director, Operations & Innovation, and Gunter Scharer - Chief Medical Officer & Medical Director.
RPRD Diagnostics
RPRD (Right Patient Right Drug) Diagnostics specializes in providing innovative pharmacogenomics solutions, including diagnostic, analysis and supporting services to clinicians, researchers and drug developers. With decades of experience in pharmacogenomics research, clinical practice, and healthcare program development, RPRD’s team of experts strives to improve patient lives using pharmacogenomics to enable precision medicine.